CCRN stock icon

Cross Country Healthcare
CCRN

$14.39
1.62%
 

About: Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement, and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.

Employees: 2,300

0
Funds holding %
of 6,702 funds
0
Analysts bullish %
of 5 analysts
News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

52% more call options, than puts

Call options by funds: $464K | Put options by funds: $305K

9% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 23

1% less funds holding

Funds holding: 173 [Q4 2023] → 171 (-2) [Q1 2024]

2.2% less ownership

Funds ownership: 104.72% [Q4 2023] → 102.52% (-2.2%) [Q1 2024]

17% less repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 69

20% less capital invested

Capital invested by funds: $833M [Q4 2023] → $666M (-$167M) [Q1 2024]

Research analyst outlook

5 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$16
11%
upside
Avg. target
$20
40%
upside
High target
$24
67%
upside

5 analyst ratings

positive
80%
neutral
20%
negative
0%
Barrington Research
Kevin Steinke
46%upside
$21
Outperform
Maintained
6 May 2024
Benchmark
Bill Sutherland
32%upside
$19
Buy
Maintained
2 May 2024
Barrington Research
Kevin Steinke
67%upside
$24
Outperform
Maintained
27 Feb 2024
Truist Securities
Tobey Sommer
11%upside
$16
Hold
Maintained
22 Feb 2024
Benchmark
Bill Sutherland
46%upside
$21
Buy
Maintained
22 Feb 2024

Financial journalist opinion